Crystallization of Cyclophosphamide Monohydrate During Lyophilization

J Pharm Sci. 2019 Mar;108(3):1195-1202. doi: 10.1016/j.xphs.2018.10.020. Epub 2018 Oct 21.

Abstract

The purpose of this study was to investigate the phase behavior of cyclophosphamide (CPA) during various stages of lyophilization, with special emphasis on obtaining crystalline CPA monohydrate (CPA-MH) in the lyophilized product. Subambient differential scanning calorimetry and low-temperature X-ray diffractometry (LTXRD) were used to study the phase behavior of CPA solution (3.7% w/v). In situ lyophilization in LTXRD chamber was used to monitor the phase transitions occurring during the drying stages. Finally, the implications of these findings were confirmed by freeze-drying the aqueous solution in a laboratory-scale freeze-dryer. The results suggested that CPA remains amorphous during freeze concentration, with a Tg' of -50°C. However, its crystallization as CPA-MH can be induced by annealing the frozen solution between -5°C and -10°C. In situ lyophilization in LTXRD showed that the CPA-MH crystallized during annealing, rapidly dehydrated during primary drying, thereby causing structural collapse. The dehydration of CPA-MH can be prevented by lowering the escaping tendency of water molecules from the crystal lattice of CPA-MH by maintaining the chamber pressure to 300, 400, or 500 mTorr. This study highlights the relationship of process parameters used during lyophilization with the solid form of lyophilized CPA.

Keywords: crystallization; dehydration; freeze-drying; hydrates; lyophilization; processing.

MeSH terms

  • Calorimetry, Differential Scanning
  • Cold Temperature
  • Crystallization
  • Cyclophosphamide / chemistry*
  • Drug Compounding / methods*
  • Drug Stability
  • Freeze Drying*
  • Phase Transition*
  • Water / chemistry
  • X-Ray Diffraction

Substances

  • Water
  • Cyclophosphamide